(Q33414595)

26 July 2017

title

Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome (English)

1 reference

antiphospholipid syndrome

26 July 2017

1 reference

1 reference

based on heuristic

inferred from title

systemic lupus erythematosus

0 references

author name string

M Deák

1

1 reference

26 July 2017

M Bocskai

2

1 reference

26 July 2017

S Burcsár

3

1 reference

26 July 2017

O Dányi

4

1 reference

26 July 2017

Z Fekete

5

1 reference

26 July 2017

L Kovács

6

1 reference

26 July 2017

publication date

11 April 2014

1 reference

26 July 2017

1 reference

26 July 2017

volume

23

1 reference

26 July 2017

issue

9

1 reference

26 July 2017

page(s)

913-918

1 reference

Mortality in systemic lupus erythematosus

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203314531839

Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203314531839

Predictive value of autoantibodies for activity of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203314531839

Autoantibodies in lupus: culprits or passive bystanders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203314531839

Premature atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203314531839

Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203314531839

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203314531839

Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203314531839

Antiphospholipid (Hughes) syndrome in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203314531839

Antiphospholipid syndrome in systemic lupus erythematosus: is the whole greater than the sum of its parts?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203314531839

Male versus female lupus: a comparison of ethnicity, clinical features, serology and outcome over a 30 year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203314531839

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203314531839

Age- and gender-related long-term renal outcome in patients with lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203314531839

Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203314531839

Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203314531839

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203314531839

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203314531839

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203314531839

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203314531839

Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203314531839

Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203314531839

21 January 2018

Identifiers

DOI

10.1177/0961203314531839

1 reference

26 July 2017

1 reference